Duration: (36:15) ?Subscribe5835 2025-02-21T01:53:03+00:00
Advances in the Management of Nontuberculous Mycobacterial Lung Disease (NTM-LD)
(29:)
Management of patients with NTM-LD: Improving adherence for optimal outcomes
(32:54)
The Changing Face of Nontuberculous Mycobacterial (NTM) Disease: Lady Windermere shares the Stage
(55:41)
NTM-LD Improving Diagnosis Individualized Treatment and Adherence
(36:15)
Watch Dr. McShane discuss the latest #NTM-LD updates from #CHEST2024 - https://bit.ly/Y24NTM-LD
(1:16:32)
Improving the Patient Experience in NTM-LD Through Diagnosis, Therapy, and AE Management
(38:55)
New guideline-based strategies for improving outcomes in patients with NTM-LD
(37:5)
What is NTM Lung Disease?
(1:18)
Patient Story: Moving Forward with NTM
(1:25)
What is NTM Lung Disease and Who is Susceptible?
(10:25)
Addressing Challenges in NTM-LD: Managing Adverse Effects to Keep Patients on Therapy
(33:2)
Confronting the Challenges of Nontuberculous Mycobacterial Lung Disease
(34:58)
Treatment of Nontuberculous Mycobacterial Infections (NTM)
(33:12)
NTM-Lung Disease: Goals of Treatment
(3:48)
Nontuberculous Mycobacterial Lung Disease Today and Tomorrow
(4:42)
ESM Webinars: NTM (non-tuberculosis mycobacteria) Pulmonary disease, from diagnosis to treatment
(58:40)
NTM-Lung Disease: Patient Management
(1:26)
Improving Outcomes for Patients With Nontuberculous Mycobacterial Lung Disease
(25:39)
What is NTM lung disease?
(1:40)
NTM-Lung Disease: Management of Patient Side Effects
(2:17)